Trial start Phase 1: An Early Feasibility Study of the BioJet™ Oral Biotherapeutic Delivery System for Administration of Therapeutic Agents in Healthy Participants source ↗
Trial start Phase 1: BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects source ↗
Upcoming milestones
Jan 15, 2027 (ESTIMATED) · Phase 1 · An Early Feasibility Study of the BioJet™ Oral Biotherapeutic Delivery System for Administration of Therapeutic Agents in Healthy Participants · NCT07849153
Estimated primary completion per ClinicalTrials.gov. Dates move.